You need to have the Flash Player installed and
a browser with JavaScript support.
Description
http://www.medpagetoday.com Stephen MacMahon, D.Sc., Ph.D., MPH, University of Sydney SAN FRANCISCO -- Intensive glucose lowering strategies reduce nephropathy but not major cardiovascular outcomes for patients with type 2 diabetes, according to results of the largest tight-control randomized trial to date.
Sign in or sign up to post comments.